A semi-quantitative sport-specific assessment of recurrent traumatic brain injury: the TraQ questionnaire and its application in American football.
Adolescent
Adult
Aggression
/ physiology
Athletic Injuries
/ complications
Attention Deficit Disorder with Hyperactivity
/ diagnosis
Brain Injuries, Traumatic
/ complications
Chronic Traumatic Encephalopathy
/ complications
Football
/ injuries
Headache
/ diagnosis
Humans
Language Disorders
/ diagnosis
Male
Middle Aged
Olfaction Disorders
/ diagnosis
Paresthesia
/ diagnosis
Pilot Projects
Psychometrics
/ instrumentation
Severity of Illness Index
Surveys and Questionnaires
Young Adult
American football
CTE
Chronic traumatic encephalopathy
TBI
TraQ
Trauma questionnaire
Traumatic brain injury
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
29
10
2018
accepted:
15
03
2019
pubmed:
20
5
2019
medline:
13
2
2020
entrez:
20
5
2019
Statut:
ppublish
Résumé
Chronic traumatic encephalopathy (CTE) is very frequent and studied among contact sport players, above all American Football. Now, the defined diagnosis is only post-mortem and, consequently, more detailed diagnostic in-vivo instruments are needed to facilitate diagnosis and to allow a follow up. This clinical questionnaire (Trauma Questionnaire-TraQ) has been designed to investigate in parallel the traumatic load and clinical and cognitive subjective symptoms. It evaluates 4 anamnestic fields (specific sport activity, all previous pathological events, clinical manifestations compatible with TBI (traumatic brain injury) or CTE and subjective perception of personal memory efficacy with PRMQ questionnaire). The aim of TraQ questionnaire is to allow a standardized follow-up of active players and to identify subclinical disturbances that may become warnings. A pilot comparative study with TraQ on 105 subjects (75 AF players and 30 comparable people without a history of contact-sports activity) revealed that AF players have an increased amount of severe head trauma, an amplified level of subjective aggressiveness, more olfactory deficits but also more speech subjective problems, previously never related with CTE. In view of the obtained results, the TraQ seems to be useful (1) to obtain a better quantification of the traumatic load; (2) to differentiate the risk of long-term neurological consequences, allowing better management of different athletes right from the pre-symptomatic phases; (3) to manage prevention strategies if regularly applied to periodic visits to sports fitness; and (4) to identify the predisposing factors for the development of CTE and other neurological consequences of TBI with follow-up studies.
Identifiants
pubmed: 31104170
doi: 10.1007/s10072-019-03853-z
pii: 10.1007/s10072-019-03853-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1909-1915Références
Memory. 2000 Sep;8(5):311-21
pubmed: 11045239
J Athl Train. 2001 Sep;36(3):303-306
pubmed: 12937500
Neurosurgery. 2005 Jul;57(1):128-34; discussion 128-34
pubmed: 15987548
Neurosurgery. 2006 Nov;59(5):1086-92; discussion 1092-3
pubmed: 17143242
Brain Inj. 2009 Jul;23(7):666-74
pubmed: 19557570
J Forensic Nurs. 2010 Spring;6(1):40-6
pubmed: 20201914
J Neurotrauma. 2010 Aug;27(8):1399-411
pubmed: 20528163
Brain. 2011 Feb;134(Pt 2):449-63
pubmed: 21193486
Surg Neurol Int. 2011;2:107
pubmed: 21886880
AJNR Am J Neuroradiol. 2013 May;34(5):951-7, S1-3
pubmed: 23179649
Ann Neurol. 2013 Apr;73(4):489-99
pubmed: 23426980
NMR Biomed. 2013 Jun;26(6):651-63
pubmed: 23456696
Nat Rev Neurol. 2013 Apr;9(4):222-30
pubmed: 23478462
NeuroRehabilitation. 2013;32(2):211-24
pubmed: 23535783
Neurology. 2013 May 14;80(20):1826-33
pubmed: 23596068
J Neurotrauma. 2015 Mar 1;32(5):314-26
pubmed: 25155288
Alzheimers Res Ther. 2014 Sep 24;6(5):68
pubmed: 25580160
Surg Neurol Int. 2016 May 06;7(Suppl 10):S263-75
pubmed: 27213113
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544